Urology FAQs
Find answers to common questions related to kidney stones, prostate issues, urinary problems, male infertility, urological cancers and advanced treatments.
Kidney Disease & Transplantation
Kidney disease is a serious condition that affects the kidneys' ability to remove waste, balance fluids, and maintain overall health. Common causes include diabetes, high blood pressure, infections, and genetic disorders. Early diagnosis and proper treatment can help slow disease progression and prevent complications. For patients with advanced kidney failure, dialysis and kidney transplantation are the primary treatment options, with transplantation often providing better long-term outcomes and quality of life. In this FAQ guide, Dr. Arif Akhtar answers the most common questions about kidney disease, dialysis, kidney transplantation, recovery, and long-term kidney health.
Your first transplant consultation is essentially a comprehensive review of your overall health, not just your kidneys. I will evaluate your cardiac status, metabolic profile, immunological workup, and any co-existing conditions that could influence surgical risk or long-term graft survival. Coming prepared with a detailed medication list, prior investigation reports, and a clear account of your kidney disease history will make this appointment far more productive for both of us.
Candidacy for renal transplantation is determined through a thorough multi-disciplinary evaluation that assesses cardiovascular fitness, absence of active malignancy, and the absence of uncontrolled systemic infections. Current evidence strongly supports transplantation as the optimal renal replacement therapy for eligible patients, offering a significant survival advantage over long-term dialysis. Age alone is not a disqualifying factor — what truly matters is your physiological reserve and overall functional status.
Dialysis is a life-sustaining bridge therapy that partially mimics kidney function by filtering waste and excess fluid, but it replaces only about 10–15% of normal kidney function and requires sessions three to four times a week indefinitely. A successful kidney transplant, on the other hand, restores near-normal renal function, liberates patients from the constraints of dialysis schedules, and is associated with significantly better long-term survival and quality of life. Data from large registry studies consistently show that transplant recipients have a mortality risk 50–70% lower than matched patients who remain on dialysis.
The longevity of a transplanted kidney depends largely on the donor source, recipient compliance with immunosuppression, and how well co-existing conditions such as hypertension and diabetes are managed. Living donor kidneys have a median graft survival exceeding 15–20 years, while deceased donor kidneys typically function well for 10–15 years, though many last considerably longer. With advances in modern immunosuppression and closer post-transplant monitoring, graft half-lives have improved meaningfully over the past two decades.
Living donor transplantation is not only possible but is actually the preferred option whenever a suitable donor is available, offering better graft outcomes and shorter waiting times compared to deceased donor transplants. The donor can be a blood relative, a spouse, or even an altruistic unrelated donor, provided they pass a rigorous medical and psychosocial evaluation. Long-term studies demonstrate that carefully screened living donors face no significant increase in their own risk of kidney disease or mortality, which is reassuring for both patients and their families.
Kidney transplant surgery is typically performed under general anaesthesia and takes approximately three to four hours. The donor kidney is placed in the iliac fossa of the lower abdomen — not in the back — and its blood vessels are anastomosed to the recipient's iliac vessels, while the ureter is connected to the bladder. In most cases, the non-functioning native kidneys are left in place unless they are causing specific problems such as recurrent infections or uncontrollable hypertension.
The cost of kidney transplantation in India varies considerably depending on the institution, city, and complexity of the case, but it is generally far more cost-effective than remaining on dialysis for five or more years when total lifetime costs are calculated. Most government-run transplant programs and several state health schemes now offer subsidized or fully covered transplantation for eligible patients. I strongly advise every patient to explore government schemes, hospital-specific financial assistance, and insurance coverage before making any decisions.
After transplantation, you will be placed on lifelong immunosuppressive therapy to prevent your immune system from rejecting the new kidney — the standard regimen typically includes a calcineurin inhibitor such as tacrolimus, an antiproliferative agent like mycophenolate mofetil, and a low-dose corticosteroid. In addition, prophylactic medications against infections such as CMV and pneumocystis are given in the initial months. Strict adherence to this regimen is non-negotiable; even occasional missed doses are a leading cause of late acute rejection and graft loss.
Most patients are mobile within 24–48 hours of surgery and are discharged from hospital within 5–7 days, provided the graft functions well and there are no early complications. However, full recovery — including return to normal daily activities and work — typically takes four to six weeks, and close outpatient monitoring is essential during this period. The first three months post-transplant are the most critical, as this is when the risk of both rejection and opportunistic infections is highest.
Travel is absolutely possible after transplantation, and many of my patients lead rich, active lives including international travel. However, certain precautions are essential: maintaining an uninterrupted supply of immunosuppressive medications, avoiding areas with high rates of endemic infections, and ensuring access to transplant medical care at your destination. I generally advise patients to wait at least three to six months post-transplant before undertaking long-distance travel, and to always carry a transplant summary card and emergency contact information.
Like any major surgical procedure, kidney transplantation carries risks including bleeding, infection, vascular thrombosis, and urine leak, though these are uncommon in experienced centres. The more long-term concerns include rejection, nephrotoxicity from immunosuppressive medications, post-transplant diabetes, hypertension, and an elevated risk of certain malignancies due to chronic immunosuppression. I always have a detailed, candid discussion with each patient about these risks weighed against the substantial survival and quality-of-life benefits that transplantation offers.
Follow-up frequency is intensive in the early post-transplant period — typically weekly visits for the first month, followed by fortnightly and then monthly reviews as the graft stabilises. After the first year, stable recipients are usually seen every three months, with annual comprehensive assessments including cancer screening and cardiovascular evaluation. Consistent attendance at these appointments is one of the most important things a transplant recipient can do to protect their graft and overall health.
Dietary management in chronic kidney disease is nuanced and should ideally be guided by a renal dietitian, as requirements change significantly depending on the stage of disease and whether the patient is on dialysis or post-transplant. In general, patients with advanced CKD need to moderate their intake of potassium, phosphorus, and sodium, while ensuring adequate caloric and protein intake to prevent malnutrition. Post-transplant dietary advice shifts considerably — protein requirements increase in the early phase, and maintaining a healthy weight becomes a priority given the metabolic effects of immunosuppression.
The vast majority of patients with early to moderate CKD can and should continue working full-time, as maintaining employment is closely linked to better mental health, financial stability, and overall quality of life. As disease progresses, fatigue and the demands of dialysis schedules may require adjustments, and most employers can accommodate part-time or flexible arrangements during this period. Post-transplant, the majority of working-age recipients return to full-time employment within three to six months, which is another compelling reason to pursue transplantation when eligible.
Routine monitoring for kidney disease patients includes serum creatinine, estimated GFR, electrolytes (particularly potassium, bicarbonate, and phosphorus), a complete blood count, and urine albumin-to-creatinine ratio. Post-transplant recipients additionally require tacrolimus drug level monitoring, CMV PCR testing in the early months, and periodic assessment of bone mineral density and lipid profiles. The frequency and specific panel of tests are tailored individually based on the stage of disease and the clinical trajectory of each patient.
Kidney disease is diagnosed through a combination of blood tests measuring serum creatinine and eGFR, urine tests looking for proteinuria and haematuria, and imaging such as renal ultrasound to assess kidney size and structure. The formal diagnosis of CKD requires evidence of kidney damage or reduced function persisting for more than three months, as a single abnormal result can sometimes be transient. In selected cases, a kidney biopsy remains the gold standard for identifying the underlying cause, particularly when the diagnosis is unclear or when specific treatment decisions depend on the histological findings.
The two most common causes of chronic kidney disease worldwide are diabetes mellitus and hypertension, which together account for over 60% of all cases requiring renal replacement therapy. Other significant causes include glomerulonephritis, polycystic kidney disease, recurrent urinary tract infections, obstructive uropathy, and prolonged use of nephrotoxic medications including certain analgesics and herbal preparations. In my clinical practice, I also encounter a significant number of patients from the subcontinent where hypertensive nephrosclerosis and diabetic nephropathy remain the dominant drivers of end-stage kidney disease.
Whether kidney disease can be reversed depends entirely on its underlying cause and how early it is identified. Conditions such as obstructive uropathy, certain forms of glomerulonephritis, and medication-induced nephrotoxicity can show meaningful improvement when the cause is treated promptly and correctly. Advanced CKD with significant fibrosis and scarring on biopsy is unfortunately largely irreversible, which is why early detection and aggressive management of risk factors like blood pressure and blood glucose control are so critical to slowing progression.
This is a question I often encounter in clinic, and it is worth clarifying that kidney disease is not itself classified into Type 1 and Type 2 in the same way diabetes is. What patients are usually referring to is the distinction between Acute Kidney Injury — a sudden, often reversible deterioration — and Chronic Kidney Disease, which develops gradually over months to years and is staged from G1 to G5 based on eGFR. Understanding which category applies to a patient fundamentally changes the management strategy and the prognosis.
For general kidney health checks and early-stage CKD, your primary care physician plays an essential role in monitoring and managing risk factors. However, I recommend referral to a nephrologist when eGFR falls below 60 mL/min/1.73m², when there is significant proteinuria, when the cause of kidney disease is unclear, or when blood pressure remains difficult to control despite standard therapy. Early specialist involvement has consistently been shown to slow disease progression and reduce complications, particularly in patients who may ultimately need renal replacement therapy.
Preparation for dialysis ideally begins months before it is actually needed, and this is one area where early nephrology referral makes an enormous practical difference. For haemodialysis, a functioning vascular access — preferably an arteriovenous fistula — needs to be created surgically and allowed to mature for several weeks before use. For peritoneal dialysis, a peritoneal catheter is placed and a period of training is required, which can often be done at home with appropriate nursing support.
Haemodialysis is commonly associated with intradialytic hypotension, muscle cramps, fatigue, and headaches during or after sessions, as well as longer-term complications including anaemia, bone disease, and cardiovascular disease. Peritoneal dialysis carries risks of peritonitis, catheter-related infections, and gradual loss of residual kidney function. Both modalities are effective at sustaining life, but neither fully replicates the continuous, around-the-clock filtration of a healthy kidney, which is why transplantation remains the superior long-term option for suitable patients.
Absolutely — the choice between home-based peritoneal dialysis or home haemodialysis and in-centre haemodialysis should be made collaboratively based on your medical suitability, home environment, support system, and personal preference. Large observational studies suggest that home dialysis modalities are associated with better preservation of residual kidney function and improved quality of life in appropriately selected patients. In our unit, we encourage an informed, patient-centred approach to this decision and provide dedicated education sessions to help families understand all available options.
Your dialysis access — whether an arteriovenous fistula, graft, or central venous catheter — is your lifeline, and protecting it must become second nature. For a fistula or graft, this means never allowing blood pressure measurements or blood draws from that arm, protecting it from compression, and reporting any changes in thrill, bruit, swelling, or skin changes to your care team immediately. Central venous catheters require meticulous sterile care during dressing changes and should be used exclusively for dialysis to minimise the risk of infection and thrombosis.
Signs of a failing transplant — rising creatinine, declining urine output, graft tenderness, or fluid retention — require urgent evaluation and should never be managed with a wait-and-watch approach. Depending on the cause, treatment options range from pulse steroid therapy for acute cellular rejection to plasmapheresis and intravenous immunoglobulin for antibody-mediated rejection. If chronic allograft nephropathy has set in, the focus shifts to optimising medical management to slow progression and preparing the patient for either re-transplantation or return to dialysis.
Having kidney disease — or even a history of kidney disease — is generally considered a contraindication to living kidney donation, as the remaining kidney must be able to sustain adequate function for the donor's lifetime. The evaluation process for any potential living donor includes comprehensive assessment of eGFR, urine studies, blood pressure, metabolic profile, and an honest discussion of long-term risks. Protecting the health of the living donor is an absolute ethical priority, and at our centre we adhere strictly to established international guidelines in this regard.
Normal kidney function is reflected by an eGFR above 90 mL/min/1.73m² with no evidence of proteinuria or structural abnormality on imaging. An eGFR between 60 and 89, in isolation, may simply reflect age-related physiological decline and does not automatically indicate disease unless accompanied by other markers of kidney damage. CKD is formally defined by an eGFR persistently below 60 mL/min/1.73m² or the presence of markers such as albuminuria, haematuria, or structural abnormalities for more than three months.
The evidence base for slowing CKD progression has expanded significantly in recent years. Tight blood pressure control — targeting below 130/80 mmHg using renin-angiotensin system blockers — combined with optimised glycaemic control in diabetic patients forms the cornerstone of management. Newer agents, particularly SGLT2 inhibitors such as empagliflozin and dapagliflozin, have demonstrated remarkable nephroprotective effects in landmark trials and are now incorporated into standard CKD management guidelines regardless of whether the patient has diabetes.
A well-prepared patient makes for a far more productive clinical consultation. I always encourage patients to ask about the specific cause of their kidney disease, the current stage of their CKD, the target blood pressure and how to achieve it, dietary restrictions relevant to their stage, and what symptoms should prompt urgent contact. Equally important is asking about the trajectory — are we in a stable phase, or is progression occurring — and at what point should discussions about renal replacement therapy begin.
A good nephrologist should combine strong clinical expertise with clear communication and genuine empathy — qualities that are just as important as technical skill in a chronic disease relationship that may span many years. I recommend seeking out specialists affiliated with established centres that have dedicated transplant programmes, dialysis units, and multidisciplinary support teams including dietitians and transplant coordinators. Patient reviews, referrals from trusted primary care physicians, and the nephrologist's willingness to explain things clearly in a language you understand are all meaningful indicators of quality.
A nephrologist is a physician with advanced subspecialty training in the diagnosis and non-surgical management of kidney diseases, fluid and electrolyte disorders, hypertension, and renal replacement therapies including dialysis. While I work as a renal transplant surgeon and urologist, I collaborate closely with nephrologists in a multidisciplinary framework — they manage the pre-transplant workup, immunosuppressive therapy post-transplant, and the long-term medical follow-up of transplant recipients. Think of the nephrologist as the kidney specialist who takes care of you medically, while the transplant surgeon takes care of you surgically.
Yes, and this relationship is bidirectional — hypertension is both a cause and a consequence of chronic kidney disease, creating a vicious cycle that accelerates renal decline if left unaddressed. Diseased kidneys impair the normal renin-angiotensin-aldosterone axis and sodium excretion, leading to volume expansion and elevated blood pressure, which in turn causes further renal damage. This is precisely why blood pressure management is the single most impactful intervention we have for slowing CKD progression, and it must be approached with discipline and consistency.
Diabetic nephropathy remains the leading cause of end-stage kidney disease globally, driven by chronic hyperglycaemia-induced damage to the glomerular capillaries, mesangium, and tubular apparatus. Clinically, it progresses from microalbuminuria through macroalbuminuria to declining eGFR, and the trajectory can be dramatically altered by achieving target HbA1c levels, controlling blood pressure with ACE inhibitors or ARBs, and now — importantly — by adding SGLT2 inhibitors which have proven both nephroprotective and cardioprotective in multiple large randomised trials. Early aggressive management of diabetes is the most powerful tool we have for preventing kidney failure in diabetic patients.
Patients with kidney disease should be especially cautious about over-the-counter supplements, as many are processed and excreted by the kidneys and can accumulate to toxic levels. Particular concern exists around high-dose vitamin C, potassium-containing supplements, herbal preparations — many of which have documented nephrotoxic potential — and protein supplements that can accelerate the decline in eGFR. I strongly advise all my patients to disclose every supplement and herbal remedy they are taking, without exception, as what is marketed as natural or harmless can sometimes be seriously damaging to a compromised kidney.
Not only is exercise safe for the vast majority of CKD patients, it is actively recommended. Growing evidence shows that regular moderate-intensity physical activity improves cardiovascular outcomes, reduces fatigue, helps with blood pressure control, and enhances overall quality of life in kidney disease patients, including those on dialysis. The key is to start gradually, avoid extreme dehydration during exercise, and discuss any new exercise programme with your nephrology team — particularly if you have significant cardiovascular co-morbidities.
Anaemia in CKD is primarily caused by reduced erythropoietin production by the failing kidneys, and it contributes meaningfully to fatigue, reduced exercise tolerance, and cardiac complications. Management involves first correcting absolute or functional iron deficiency, which is extremely common and often overlooked, followed by erythropoiesis-stimulating agents when haemoglobin remains below target despite adequate iron stores. The KDIGO guidelines recommend targeting a haemoglobin of 10–11.5 g/dL in most CKD patients, avoiding over-correction above 13 g/dL which is associated with increased cardiovascular events.
Peer support is an often underestimated but genuinely powerful component of the transplant journey. In India, organisations such as the Kidney Federation of India and hospital-based transplant support groups offer platforms where patients can connect with others who have walked the same path. I encourage all my transplant recipients to engage with these communities, as they provide practical advice about daily life post-transplant, emotional reassurance during uncertain moments, and advocacy for better access to transplantation across the country.
Pregnancy after kidney transplantation is possible, but it requires very careful planning, timing, and close coordination between the transplant team, a maternal-foetal medicine specialist, and the nephrologist. Current recommendations advise waiting at least one to two years post-transplant until graft function is stable, immunosuppression has been optimised to agents considered safer in pregnancy — typically replacing mycophenolate mofetil with azathioprine — and blood pressure is well controlled. Outcomes in well-selected patients have improved considerably over time, though pregnancies in transplant recipients remain higher risk and require intensive monitoring throughout.
In India, coverage for kidney transplantation and dialysis varies widely by insurer and policy type, and I strongly recommend that patients review their policy documents carefully and consult their insurer before committing to a treatment plan. Government health schemes such as Ayushman Bharat PM-JAY offer coverage for renal transplantation at empanelled hospitals for eligible beneficiaries, which has been a significant step forward for access to care. It is equally important to plan for the ongoing cost of immunosuppressive medications post-transplant, which may or may not be covered by standard health insurance.
Rejection can be clinically silent in its early stages, which is why regular monitoring of creatinine and other graft function parameters is so critical even when you feel perfectly well. Warning signs that should prompt immediate contact with your transplant centre include a rise in serum creatinine of more than 20–25% from baseline, reduced urine output, graft swelling or tenderness, fever, or fluid retention. A transplant kidney biopsy remains the definitive diagnostic tool for suspected rejection, and when caught early and treated appropriately, many rejection episodes can be successfully reversed without permanent damage to the graft.
The Complete Kidney Stone Patient Guide
Kidney stones are hard mineral deposits that form in the kidneys and can cause severe pain, urinary symptoms, and complications if left untreated. They may develop due to dehydration, dietary factors, genetics, or underlying medical conditions. Treatment depends on the stone's size, location, and symptoms, ranging from increased fluid intake and medications to advanced minimally invasive procedures. In this comprehensive FAQ guide, Dr. Arif Akhtar answers the most common questions about kidney stone symptoms, treatment options, recovery, prevention, workplace concerns, and long-term kidney stone management to help patients make informed healthcare decisions.
This section provides a patient-friendly explanation based on current urological evidence. Management depends on stone size, location, symptoms, infection status, kidney function, and individual risk factors. Patients should consult a qualified urologist for personalized treatment and prevention strategies.
This section provides a patient-friendly explanation based on current urological evidence. Management depends on stone size, location, symptoms, infection status, kidney function, and individual risk factors. Patients should consult a qualified urologist for personalized treatment and prevention strategies.
This section provides a patient-friendly explanation based on current urological evidence. Management depends on stone size, location, symptoms, infection status, kidney function, and individual risk factors. Patients should consult a qualified urologist for personalized treatment and prevention strategies.
This section provides a patient-friendly explanation based on current urological evidence. Management depends on stone size, location, symptoms, infection status, kidney function, and individual risk factors. Patients should consult a qualified urologist for personalized treatment and prevention strategies.
This section provides a patient-friendly explanation based on current urological evidence. Management depends on stone size, location, symptoms, infection status, kidney function, and individual risk factors. Patients should consult a qualified urologist for personalized treatment and prevention strategies.
This section provides a patient-friendly explanation based on current urological evidence. Management depends on stone size, location, symptoms, infection status, kidney function, and individual risk factors. Patients should consult a qualified urologist for personalized treatment and prevention strategies.
This section provides a patient-friendly explanation based on current urological evidence. Management depends on stone size, location, symptoms, infection status, kidney function, and individual risk factors. Patients should consult a qualified urologist for personalized treatment and prevention strategies.
This section provides a patient-friendly explanation based on current urological evidence. Management depends on stone size, location, symptoms, infection status, kidney function, and individual risk factors. Patients should consult a qualified urologist for personalized treatment and prevention strategies.
This section provides a patient-friendly explanation based on current urological evidence. Management depends on stone size, location, symptoms, infection status, kidney function, and individual risk factors. Patients should consult a qualified urologist for personalized treatment and prevention strategies.
This section provides a patient-friendly explanation based on current urological evidence. Management depends on stone size, location, symptoms, infection status, kidney function, and individual risk factors. Patients should consult a qualified urologist for personalized treatment and prevention strategies.
This section provides a patient-friendly explanation based on current urological evidence. Management depends on stone size, location, symptoms, infection status, kidney function, and individual risk factors. Patients should consult a qualified urologist for personalized treatment and prevention strategies.
This section provides a patient-friendly explanation based on current urological evidence. Management depends on stone size, location, symptoms, infection status, kidney function, and individual risk factors. Patients should consult a qualified urologist for personalized treatment and prevention strategies.
This section provides a patient-friendly explanation based on current urological evidence. Management depends on stone size, location, symptoms, infection status, kidney function, and individual risk factors. Patients should consult a qualified urologist for personalized treatment and prevention strategies.
This section provides a patient-friendly explanation based on current urological evidence. Management depends on stone size, location, symptoms, infection status, kidney function, and individual risk factors. Patients should consult a qualified urologist for personalized treatment and prevention strategies.
This section provides a patient-friendly explanation based on current urological evidence. Management depends on stone size, location, symptoms, infection status, kidney function, and individual risk factors. Patients should consult a qualified urologist for personalized treatment and prevention strategies.
This section provides a patient-friendly explanation based on current urological evidence. Management depends on stone size, location, symptoms, infection status, kidney function, and individual risk factors. Patients should consult a qualified urologist for personalized treatment and prevention strategies.
This section provides a patient-friendly explanation based on current urological evidence. Management depends on stone size, location, symptoms, infection status, kidney function, and individual risk factors. Patients should consult a qualified urologist for personalized treatment and prevention strategies.
This section provides a patient-friendly explanation based on current urological evidence. Management depends on stone size, location, symptoms, infection status, kidney function, and individual risk factors. Patients should consult a qualified urologist for personalized treatment and prevention strategies.
This section provides a patient-friendly explanation based on current urological evidence. Management depends on stone size, location, symptoms, infection status, kidney function, and individual risk factors. Patients should consult a qualified urologist for personalized treatment and prevention strategies.
This section provides a patient-friendly explanation based on current urological evidence. Management depends on stone size, location, symptoms, infection status, kidney function, and individual risk factors. Patients should consult a qualified urologist for personalized treatment and prevention strategies.
This section provides a patient-friendly explanation based on current urological evidence. Management depends on stone size, location, symptoms, infection status, kidney function, and individual risk factors. Patients should consult a qualified urologist for personalized treatment and prevention strategies.
This section provides a patient-friendly explanation based on current urological evidence. Management depends on stone size, location, symptoms, infection status, kidney function, and individual risk factors. Patients should consult a qualified urologist for personalized treatment and prevention strategies.
This section provides a patient-friendly explanation based on current urological evidence. Management depends on stone size, location, symptoms, infection status, kidney function, and individual risk factors. Patients should consult a qualified urologist for personalized treatment and prevention strategies.
This section provides a patient-friendly explanation based on current urological evidence. Management depends on stone size, location, symptoms, infection status, kidney function, and individual risk factors. Patients should consult a qualified urologist for personalized treatment and prevention strategies.
This section provides a patient-friendly explanation based on current urological evidence. Management depends on stone size, location, symptoms, infection status, kidney function, and individual risk factors. Patients should consult a qualified urologist for personalized treatment and prevention strategies.
This section provides a patient-friendly explanation based on current urological evidence. Management depends on stone size, location, symptoms, infection status, kidney function, and individual risk factors. Patients should consult a qualified urologist for personalized treatment and prevention strategies.
This section provides a patient-friendly explanation based on current urological evidence. Management depends on stone size, location, symptoms, infection status, kidney function, and individual risk factors. Patients should consult a qualified urologist for personalized treatment and prevention strategies.
This section provides a patient-friendly explanation based on current urological evidence. Management depends on stone size, location, symptoms, infection status, kidney function, and individual risk factors. Patients should consult a qualified urologist for personalized treatment and prevention strategies.
This section provides a patient-friendly explanation based on current urological evidence. Management depends on stone size, location, symptoms, infection status, kidney function, and individual risk factors. Patients should consult a qualified urologist for personalized treatment and prevention strategies.
This section provides a patient-friendly explanation based on current urological evidence. Management depends on stone size, location, symptoms, infection status, kidney function, and individual risk factors. Patients should consult a qualified urologist for personalized treatment and prevention strategies.
This section provides a patient-friendly explanation based on current urological evidence. Management depends on stone size, location, symptoms, infection status, kidney function, and individual risk factors. Patients should consult a qualified urologist for personalized treatment and prevention strategies.
This section provides a patient-friendly explanation based on current urological evidence. Management depends on stone size, location, symptoms, infection status, kidney function, and individual risk factors. Patients should consult a qualified urologist for personalized treatment and prevention strategies.
This section provides a patient-friendly explanation based on current urological evidence. Management depends on stone size, location, symptoms, infection status, kidney function, and individual risk factors. Patients should consult a qualified urologist for personalized treatment and prevention strategies.
This section provides a patient-friendly explanation based on current urological evidence. Management depends on stone size, location, symptoms, infection status, kidney function, and individual risk factors. Patients should consult a qualified urologist for personalized treatment and prevention strategies.
This section provides a patient-friendly explanation based on current urological evidence. Management depends on stone size, location, symptoms, infection status, kidney function, and individual risk factors. Patients should consult a qualified urologist for personalized treatment and prevention strategies.
This section provides a patient-friendly explanation based on current urological evidence. Management depends on stone size, location, symptoms, infection status, kidney function, and individual risk factors. Patients should consult a qualified urologist for personalized treatment and prevention strategies.
This section provides a patient-friendly explanation based on current urological evidence. Management depends on stone size, location, symptoms, infection status, kidney function, and individual risk factors. Patients should consult a qualified urologist for personalized treatment and prevention strategies.
This section provides a patient-friendly explanation based on current urological evidence. Management depends on stone size, location, symptoms, infection status, kidney function, and individual risk factors. Patients should consult a qualified urologist for personalized treatment and prevention strategies.
This section provides a patient-friendly explanation based on current urological evidence. Management depends on stone size, location, symptoms, infection status, kidney function, and individual risk factors. Patients should consult a qualified urologist for personalized treatment and prevention strategies.
This section provides a patient-friendly explanation based on current urological evidence. Management depends on stone size, location, symptoms, infection status, kidney function, and individual risk factors. Patients should consult a qualified urologist for personalized treatment and prevention strategies.
Penile Implant Surgery
Penile implant surgery is a proven treatment for men with erectile dysfunction (ED) that does not respond to medications, injections, or other therapies. Modern penile prostheses provide reliable, long-lasting erections with high patient and partner satisfaction rates. The procedure is safe, discreet, and can significantly improve sexual confidence, intimacy, and quality of life. In this comprehensive FAQ guide, Dr. Arif Akhtar answers the most common questions about penile implant surgery, recovery, costs, risks, implant types, candidacy, sexual function, and long-term outcomes to help patients make informed treatment decisions.
→ Recovery timeline for returning to work
As a urological surgeon performing penile prosthesis implantations, I advise most patients to take 2 to 4 weeks off work, depending on the physical demands of their occupation. Sedentary or desk-based professionals can typically return within 2 weeks, whereas those in physically demanding jobs — involving heavy lifting, prolonged standing, or manual labour — should anticipate 4 to 6 weeks before resuming full duties. A 2024 review published in the Asian Journal of Andrology confirms that with modern minimally invasive infrapubic or penoscrotal approaches, post-operative discomfort significantly diminishes within the first two weeks, allowing most patients to resume light activities promptly. I consistently advise my patients that activity pacing in the early recovery phase directly influences long-term device satisfaction.
As a urological surgeon performing penile prosthesis implantations, I advise most patients to take 2 to 4 weeks off work, depending on the physical demands of their occupation. Sedentary or desk-based professionals can typically return within 2 weeks, whereas those in physically demanding jobs — involving heavy lifting, prolonged standing, or manual labour — should anticipate 4 to 6 weeks before resuming full duties. A 2024 review published in the Asian Journal of Andrology confirms that with modern minimally invasive infrapubic or penoscrotal approaches, post-operative discomfort significantly diminishes within the first two weeks, allowing most patients to resume light activities promptly. I consistently advise my patients that activity pacing in the early recovery phase directly influences long-term device satisfaction.
→ Age eligibility for the procedure
Age alone is never a contraindication for penile implant surgery. In my practice, I regularly perform penile prosthesis implantations in men in their 70s and even 80s, with excellent outcomes provided their cardiovascular fitness and anaesthetic risk are well managed. The 2025 meta-analysis by Corona et al. published in Andrology, which examined 12,132 patients with a mean age of 58.6 years across 83 studies, demonstrated an overall patient satisfaction rate of 83%, and importantly, satisfaction was found to be independent of patient age. Older patients with refractory erectile dysfunction — particularly those with post-prostatectomy ED, Peyronie's disease, or severe vascular insufficiency — derive tremendous quality-of-life benefit, and I encourage them to pursue a thorough pre-operative assessment rather than assume age disqualifies them.
Age alone is never a contraindication for penile implant surgery. In my practice, I regularly perform penile prosthesis implantations in men in their 70s and even 80s, with excellent outcomes provided their cardiovascular fitness and anaesthetic risk are well managed. The 2025 meta-analysis by Corona et al. published in Andrology, which examined 12,132 patients with a mean age of 58.6 years across 83 studies, demonstrated an overall patient satisfaction rate of 83%, and importantly, satisfaction was found to be independent of patient age. Older patients with refractory erectile dysfunction — particularly those with post-prostatectomy ED, Peyronie's disease, or severe vascular insufficiency — derive tremendous quality-of-life benefit, and I encourage them to pursue a thorough pre-operative assessment rather than assume age disqualifies them.
→ Day-by-day healing expectations
In the immediate post-operative period — the first 48 to 72 hours — patients typically experience perineal swelling, bruising, and moderate discomfort managed with oral analgesics and anti-inflammatory agents. By the end of the first week, most patients are ambulatory and managing personal hygiene independently; sutures are usually absorbable and require no removal. The 2024 review in the Asian Journal of Andrology highlights that minimally invasive surgical techniques have substantially reduced intra-operative blood loss and early post-operative pain scores. Device cycling — the gentle inflation and deflation exercises taught at the 4-to-6 week follow-up visit — is critical to prevent corporal fibrosis and promote proper device seating; full sexual activity is typically resumed at 6 to 8 weeks post-operatively.
In the immediate post-operative period — the first 48 to 72 hours — patients typically experience perineal swelling, bruising, and moderate discomfort managed with oral analgesics and anti-inflammatory agents. By the end of the first week, most patients are ambulatory and managing personal hygiene independently; sutures are usually absorbable and require no removal. The 2024 review in the Asian Journal of Andrology highlights that minimally invasive surgical techniques have substantially reduced intra-operative blood loss and early post-operative pain scores. Device cycling — the gentle inflation and deflation exercises taught at the 4-to-6 week follow-up visit — is critical to prevent corporal fibrosis and promote proper device seating; full sexual activity is typically resumed at 6 to 8 weeks post-operatively.
→ Sexual activity timeline post-surgery
I advise all my patients to refrain from sexual intercourse for a minimum of 6 weeks following penile prosthesis implantation, with many surgeons now extending this to 8 weeks to ensure complete wound healing and device integration. During this period, I initiate a structured penile rehabilitation programme at the 4-week mark that involves daily cycling of the inflatable device to maintain corporal length and pliability. A 2024 prospective study published in the International Journal of Impotence Research confirmed that outpatient inflatable penile prosthesis implantation allows for safe early rehabilitation without increased complication risk. Prematurely engaging in intercourse can risk wound dehiscence, device malposition, or reservoir herniation, so adherence to this timeline is non-negotiable in my practice.
I advise all my patients to refrain from sexual intercourse for a minimum of 6 weeks following penile prosthesis implantation, with many surgeons now extending this to 8 weeks to ensure complete wound healing and device integration. During this period, I initiate a structured penile rehabilitation programme at the 4-week mark that involves daily cycling of the inflatable device to maintain corporal length and pliability. A 2024 prospective study published in the International Journal of Impotence Research confirmed that outpatient inflatable penile prosthesis implantation allows for safe early rehabilitation without increased complication risk. Prematurely engaging in intercourse can risk wound dehiscence, device malposition, or reservoir herniation, so adherence to this timeline is non-negotiable in my practice.
→ Appearance and detection concerns
This is one of the most common questions I receive, and the reassuring answer is that modern three-piece inflatable prostheses are virtually undetectable to a partner. When deflated, the device lies naturally along the penile shaft with no visible external hardware, and when inflated, it closely mimics a natural erection in both girth and rigidity. Data from European satisfaction studies — referenced in Contemporary Patient Satisfaction Reviews — show that 82% of partners reported satisfying improvements in their sexual lives post-implant, with the majority unaware of any artificial quality to the erection. I counsel patients that the pump mechanism is discreetly placed within the scrotum and is palpable only on careful self-examination; in clinical practice, partners rarely identify any detectable difference.
This is one of the most common questions I receive, and the reassuring answer is that modern three-piece inflatable prostheses are virtually undetectable to a partner. When deflated, the device lies naturally along the penile shaft with no visible external hardware, and when inflated, it closely mimics a natural erection in both girth and rigidity. Data from European satisfaction studies — referenced in Contemporary Patient Satisfaction Reviews — show that 82% of partners reported satisfying improvements in their sexual lives post-implant, with the majority unaware of any artificial quality to the erection. I counsel patients that the pump mechanism is discreetly placed within the scrotum and is palpable only on careful self-examination; in clinical practice, partners rarely identify any detectable difference.
→ Longevity and revision surgery frequency
Modern three-piece inflatable penile prostheses are remarkably durable devices. A landmark 2025 study by Moncada et al. published in the Asian Journal of Andrology, tracking device survival over 27 years using Kaplan-Meier analysis, demonstrated excellent long-term mechanical reliability across multiple prosthesis generations. Mechanical reliability rates are generally cited at approximately 92% at 3 years and 86% at 5 years for the AMS 700CX series, while newer-generation devices with enhanced cylinder and tubing technology are performing even better. In my practice, I counsel patients to expect a device lifespan of 10 to 15 years under normal usage, after which elective revision surgery — not always urgently required — can be scheduled, and revision surgery itself is technically straightforward in experienced hands.
Modern three-piece inflatable penile prostheses are remarkably durable devices. A landmark 2025 study by Moncada et al. published in the Asian Journal of Andrology, tracking device survival over 27 years using Kaplan-Meier analysis, demonstrated excellent long-term mechanical reliability across multiple prosthesis generations. Mechanical reliability rates are generally cited at approximately 92% at 3 years and 86% at 5 years for the AMS 700CX series, while newer-generation devices with enhanced cylinder and tubing technology are performing even better. In my practice, I counsel patients to expect a device lifespan of 10 to 15 years under normal usage, after which elective revision surgery — not always urgently required — can be scheduled, and revision surgery itself is technically straightforward in experienced hands.
→ Realistic outcome expectations
Penile implant surgery carries one of the highest satisfaction rates of any elective urological procedure. The 2025 systematic review and meta-analysis by Corona et al. in Andrology — analysing 12,132 patients across 83 studies — reported an overall patient satisfaction rate of 83%, with higher rates observed in recipients of three-piece inflatable prostheses. Partner satisfaction is similarly impressive: pooled data consistently demonstrate partner satisfaction rates in excess of 80%, with many studies reporting that 97% of patients would recommend the procedure to others facing erectile dysfunction. These figures place penile prosthesis implantation above PDE5 inhibitor therapy and intracavernosal injection therapy in terms of long-term patient-reported satisfaction, a fact I emphasise during pre-operative counselling.
Penile implant surgery carries one of the highest satisfaction rates of any elective urological procedure. The 2025 systematic review and meta-analysis by Corona et al. in Andrology — analysing 12,132 patients across 83 studies — reported an overall patient satisfaction rate of 83%, with higher rates observed in recipients of three-piece inflatable prostheses. Partner satisfaction is similarly impressive: pooled data consistently demonstrate partner satisfaction rates in excess of 80%, with many studies reporting that 97% of patients would recommend the procedure to others facing erectile dysfunction. These figures place penile prosthesis implantation above PDE5 inhibitor therapy and intracavernosal injection therapy in terms of long-term patient-reported satisfaction, a fact I emphasise during pre-operative counselling.
→ Eligibility and screening criteria
The ideal candidate for penile prosthesis implantation is a man with organic erectile dysfunction that has failed to respond adequately to first- and second-line therapies, including PDE5 inhibitors and intracavernosal injections. Common indications in my practice include post-radical prostatectomy ED, severe vascular ED, Peyronie's disease with concurrent ED, and diabetes-associated ED refractory to medical management. Pre-operative evaluation includes a thorough history, physical examination, dynamic duplex ultrasound of the penile vasculature, hormonal panel, glycaemic assessment (HbA1c in diabetic patients), and an anaesthetic fitness review. The 2024 StatPearls update on penile prosthesis implantation emphasises that pre-operative optimisation — particularly glycaemic control, smoking cessation, and cardiovascular risk reduction — significantly improves peri-operative outcomes.
The ideal candidate for penile prosthesis implantation is a man with organic erectile dysfunction that has failed to respond adequately to first- and second-line therapies, including PDE5 inhibitors and intracavernosal injections. Common indications in my practice include post-radical prostatectomy ED, severe vascular ED, Peyronie's disease with concurrent ED, and diabetes-associated ED refractory to medical management. Pre-operative evaluation includes a thorough history, physical examination, dynamic duplex ultrasound of the penile vasculature, hormonal panel, glycaemic assessment (HbA1c in diabetic patients), and an anaesthetic fitness review. The 2024 StatPearls update on penile prosthesis implantation emphasises that pre-operative optimisation — particularly glycaemic control, smoking cessation, and cardiovascular risk reduction — significantly improves peri-operative outcomes.
→ Mobility and activity restrictions
The vast majority of my patients are walking independently and comfortably within 24 to 48 hours of surgery. The procedure itself does not involve lower limb structures, and post-operative ambulation is actively encouraged to reduce the risk of deep vein thrombosis. There may be mild perineal discomfort and scrotal swelling in the first week that causes a slightly wide-based gait, but this resolves progressively. By 2 weeks post-operatively, almost all patients report completely normal walking with minimal to no residual discomfort; I advise avoidance of strenuous physical activity — such as cycling, heavy gym work, or prolonged squatting — for 4 to 6 weeks to allow complete incision healing and device capsule formation.
The vast majority of my patients are walking independently and comfortably within 24 to 48 hours of surgery. The procedure itself does not involve lower limb structures, and post-operative ambulation is actively encouraged to reduce the risk of deep vein thrombosis. There may be mild perineal discomfort and scrotal swelling in the first week that causes a slightly wide-based gait, but this resolves progressively. By 2 weeks post-operatively, almost all patients report completely normal walking with minimal to no residual discomfort; I advise avoidance of strenuous physical activity — such as cycling, heavy gym work, or prolonged squatting — for 4 to 6 weeks to allow complete incision healing and device capsule formation.
→ Anesthesia details and sedation options
Penile prosthesis implantation can be safely performed under general anaesthesia, spinal (subarachnoid block) anaesthesia, or in select cases, deep intravenous sedation with local anaesthetic infiltration. In my practice, I most commonly use spinal anaesthesia, which offers excellent operative conditions, reduces systemic drug exposure, and provides superior post-operative analgesia with faster recovery room discharge. A 2024 prospective single-centre study in the International Journal of Impotence Research confirmed that outpatient inflatable penile prosthesis implantation under spinal or general anaesthesia is safe and feasible with minimal complication risk. The choice of anaesthetic modality is a shared decision made in collaboration with our anaesthetist team, tailored to the individual patient's comorbidities, BMI, and personal preference.
Penile prosthesis implantation can be safely performed under general anaesthesia, spinal (subarachnoid block) anaesthesia, or in select cases, deep intravenous sedation with local anaesthetic infiltration. In my practice, I most commonly use spinal anaesthesia, which offers excellent operative conditions, reduces systemic drug exposure, and provides superior post-operative analgesia with faster recovery room discharge. A 2024 prospective single-centre study in the International Journal of Impotence Research confirmed that outpatient inflatable penile prosthesis implantation under spinal or general anaesthesia is safe and feasible with minimal complication risk. The choice of anaesthetic modality is a shared decision made in collaboration with our anaesthetist team, tailored to the individual patient's comorbidities, BMI, and personal preference.
→ Pricing and insurance coverage
The total cost of penile prosthesis implantation varies depending on the type of device selected, the surgical facility, and the country of treatment. In India, the procedure typically ranges from INR 4 to 8 lakhs for an inflatable three-piece prosthesis inclusive of the device, surgeon fees, anaesthesia, and hospitalisation, with malleable prostheses being considerably more economical. Internationally, costs in the United States range from USD 15,000 to 30,000; however, insurance coverage is increasingly available when organic erectile dysfunction is documented. I advise patients to obtain a detailed cost breakdown from the hospital billing department and to explore insurance pre-authorisation thoroughly, as many national health schemes and private insurers do cover penile prosthesis implantation when medical necessity is established.
The total cost of penile prosthesis implantation varies depending on the type of device selected, the surgical facility, and the country of treatment. In India, the procedure typically ranges from INR 4 to 8 lakhs for an inflatable three-piece prosthesis inclusive of the device, surgeon fees, anaesthesia, and hospitalisation, with malleable prostheses being considerably more economical. Internationally, costs in the United States range from USD 15,000 to 30,000; however, insurance coverage is increasingly available when organic erectile dysfunction is documented. I advise patients to obtain a detailed cost breakdown from the hospital billing department and to explore insurance pre-authorisation thoroughly, as many national health schemes and private insurers do cover penile prosthesis implantation when medical necessity is established.
→ Potential complications and risks
Like all surgical procedures, penile prosthesis implantation carries a defined risk profile that I discuss with every patient during pre-operative counselling. Short-term side effects include post-operative pain, scrotal haematoma, and temporary urinary discomfort, most of which resolve within the first 2 weeks. The most clinically significant complication is device infection, which occurs in 1 to 3% of primary implantations — a figure supported by the large 2025 real-world analysis of 18,475 patients published in the Journal of Sexual Medicine, which reported an overall 3-year infection rate of 3.1%. Other recognised complications include mechanical failure, device migration, erosion through penile or urethral skin, and — notably — perceived penile length reduction due to post-operative oedema and corporal remodelling, which I discuss transparently with all patients to ensure realistic expectations.
Like all surgical procedures, penile prosthesis implantation carries a defined risk profile that I discuss with every patient during pre-operative counselling. Short-term side effects include post-operative pain, scrotal haematoma, and temporary urinary discomfort, most of which resolve within the first 2 weeks. The most clinically significant complication is device infection, which occurs in 1 to 3% of primary implantations — a figure supported by the large 2025 real-world analysis of 18,475 patients published in the Journal of Sexual Medicine, which reported an overall 3-year infection rate of 3.1%. Other recognised complications include mechanical failure, device migration, erosion through penile or urethral skin, and — notably — perceived penile length reduction due to post-operative oedema and corporal remodelling, which I discuss transparently with all patients to ensure realistic expectations.
→ Understanding the mechanism and operation
The three-piece inflatable penile prosthesis — the gold standard device I most commonly implant — consists of three components: paired intracorporal cylinders placed within the corpora cavernosa, a fluid reservoir implanted in the prevesical space (space of Retzius), and a pump mechanism located in the scrotum. To achieve an erection, the patient squeezes the scrotal pump, which transfers saline from the reservoir into the cylinders, creating a natural-appearing, rigid erection. Deflation is achieved by pressing the release valve on the pump, allowing fluid to return to the reservoir. Modern devices such as the AMS 700 series and Coloplast Titan feature lock-out valves and enhanced cylinder weave patterns that increase durability and improve the quality of erection achieved, as reviewed comprehensively in the 2024 Asian Journal of Andrology update.
The three-piece inflatable penile prosthesis — the gold standard device I most commonly implant — consists of three components: paired intracorporal cylinders placed within the corpora cavernosa, a fluid reservoir implanted in the prevesical space (space of Retzius), and a pump mechanism located in the scrotum. To achieve an erection, the patient squeezes the scrotal pump, which transfers saline from the reservoir into the cylinders, creating a natural-appearing, rigid erection. Deflation is achieved by pressing the release valve on the pump, allowing fluid to return to the reservoir. Modern devices such as the AMS 700 series and Coloplast Titan feature lock-out valves and enhanced cylinder weave patterns that increase durability and improve the quality of erection achieved, as reviewed comprehensively in the 2024 Asian Journal of Andrology update.
→ Comparing implant types
Semi-rigid (malleable) penile prostheses consist of paired bendable rods implanted in the corpora cavernosa; the penis remains in a constant semi-erect state and is manually positioned upward for intercourse or downward for concealment. Inflatable prostheses — available as two-piece or three-piece configurations — allow the patient to achieve on-demand erections and full flaccidity, far more closely mimicking natural erectile physiology. Current guidelines and the 2024 Asian Journal of Andrology review both endorse three-piece inflatable devices as offering the highest patient and partner satisfaction, with the 2025 meta-analysis by Corona et al. specifically demonstrating that satisfaction rates were significantly higher with three-piece compared to malleable devices. I select malleable prostheses primarily for patients with significant manual dexterity issues, cognitive limitations, or those requiring shorter operative times due to medical complexity.
Semi-rigid (malleable) penile prostheses consist of paired bendable rods implanted in the corpora cavernosa; the penis remains in a constant semi-erect state and is manually positioned upward for intercourse or downward for concealment. Inflatable prostheses — available as two-piece or three-piece configurations — allow the patient to achieve on-demand erections and full flaccidity, far more closely mimicking natural erectile physiology. Current guidelines and the 2024 Asian Journal of Andrology review both endorse three-piece inflatable devices as offering the highest patient and partner satisfaction, with the 2025 meta-analysis by Corona et al. specifically demonstrating that satisfaction rates were significantly higher with three-piece compared to malleable devices. I select malleable prostheses primarily for patients with significant manual dexterity issues, cognitive limitations, or those requiring shorter operative times due to medical complexity.
→ Sexual satisfaction and sensation concerns
Penile sensation — both tactile and orgasmic — is entirely preserved with penile prosthesis implantation, as the surgery does not involve the dorsal neurovascular bundle responsible for sensory innervation. The implant replaces the mechanical erectile function only; ejaculation, libido, and penile sensation remain intact. The 2025 Corona et al. meta-analysis reported that an overwhelming majority of patients and partners described sex with the implant as satisfying and natural, with 97% of patients in certain cohorts stating they would recommend the surgery to others. The rigidity and warmth of the inflated device closely replicate a natural erection, and with proper pre-operative counselling on realistic expectations — including changes in perceived penile length — my patients consistently report high post-operative sexual satisfaction.
Penile sensation — both tactile and orgasmic — is entirely preserved with penile prosthesis implantation, as the surgery does not involve the dorsal neurovascular bundle responsible for sensory innervation. The implant replaces the mechanical erectile function only; ejaculation, libido, and penile sensation remain intact. The 2025 Corona et al. meta-analysis reported that an overwhelming majority of patients and partners described sex with the implant as satisfying and natural, with 97% of patients in certain cohorts stating they would recommend the surgery to others. The rigidity and warmth of the inflated device closely replicate a natural erection, and with proper pre-operative counselling on realistic expectations — including changes in perceived penile length — my patients consistently report high post-operative sexual satisfaction.
→ Procedure duration expectations
In experienced hands, primary penile prosthesis implantation typically takes 60 to 90 minutes of operative time. The infrapubic and penoscrotal approaches — the two most widely used incision sites globally, as confirmed by the 2024-2025 ESGURS global survey — both allow efficient access to the corpora cavernosa, with each having specific technical advantages. Revision surgery or implantation in the setting of corporal fibrosis — such as after priapism, previous surgery, or Peyronie's disease — significantly increases operative complexity and duration, often requiring specialised instruments and techniques. I inform patients that total time in the surgical facility, including anaesthesia induction and recovery, is typically 3 to 4 hours, and most patients are discharged the same day or after a single overnight stay.
In experienced hands, primary penile prosthesis implantation typically takes 60 to 90 minutes of operative time. The infrapubic and penoscrotal approaches — the two most widely used incision sites globally, as confirmed by the 2024-2025 ESGURS global survey — both allow efficient access to the corpora cavernosa, with each having specific technical advantages. Revision surgery or implantation in the setting of corporal fibrosis — such as after priapism, previous surgery, or Peyronie's disease — significantly increases operative complexity and duration, often requiring specialised instruments and techniques. I inform patients that total time in the surgical facility, including anaesthesia induction and recovery, is typically 3 to 4 hours, and most patients are discharged the same day or after a single overnight stay.
→ Hygiene and wound care post-op
I advise patients to avoid wetting the incision site for the first 48 to 72 hours post-operatively, after which gentle showering is permitted — taking care to pat the wound dry thoroughly afterwards rather than rubbing. Immersion bathing, swimming pools, and hot tubs should be strictly avoided for a minimum of 4 to 6 weeks until complete wound healing has occurred, as standing water represents a significant infection vector for implanted prosthetic material. Meticulous incision hygiene is especially critical in diabetic patients and those who are immunocompromised, where wound healing may be delayed; in these patients I prescribe extended topical antiseptic wound care. All wound care instructions are provided in written format at discharge and reviewed at the first post-operative appointment.
I advise patients to avoid wetting the incision site for the first 48 to 72 hours post-operatively, after which gentle showering is permitted — taking care to pat the wound dry thoroughly afterwards rather than rubbing. Immersion bathing, swimming pools, and hot tubs should be strictly avoided for a minimum of 4 to 6 weeks until complete wound healing has occurred, as standing water represents a significant infection vector for implanted prosthetic material. Meticulous incision hygiene is especially critical in diabetic patients and those who are immunocompromised, where wound healing may be delayed; in these patients I prescribe extended topical antiseptic wound care. All wound care instructions are provided in written format at discharge and reviewed at the first post-operative appointment.
→ Pre-surgery evaluation process
The first consultation for penile prosthesis implantation is a comprehensive, unhurried appointment that I structure around four core elements: a detailed sexual and medical history, a focused physical examination, review of prior investigations, and an in-depth discussion of device options and outcomes. I assess erectile function using validated instruments such as the IIEF-5 questionnaire and review all prior treatment attempts — oral medications, vacuum erection devices, and intracavernosal injections. Dynamic penile duplex ultrasound is ordered if vascular assessment has not been recently performed, and hormonal evaluation including testosterone is reviewed. I encourage patients to attend with their partner whenever possible, as partner involvement in the decision-making process is strongly associated with higher post-operative satisfaction, as validated in multiple studies including those referenced in the 2025 Corona meta-analysis.
The first consultation for penile prosthesis implantation is a comprehensive, unhurried appointment that I structure around four core elements: a detailed sexual and medical history, a focused physical examination, review of prior investigations, and an in-depth discussion of device options and outcomes. I assess erectile function using validated instruments such as the IIEF-5 questionnaire and review all prior treatment attempts — oral medications, vacuum erection devices, and intracavernosal injections. Dynamic penile duplex ultrasound is ordered if vascular assessment has not been recently performed, and hormonal evaluation including testosterone is reviewed. I encourage patients to attend with their partner whenever possible, as partner involvement in the decision-making process is strongly associated with higher post-operative satisfaction, as validated in multiple studies including those referenced in the 2025 Corona meta-analysis.
→ Surgeon selection and credentials
Selecting an appropriately trained and experienced penile implant surgeon is arguably the single most important decision a patient makes in this journey. I recommend seeking a board-certified urologist with subspecialty training in andrology or uro-oncology and reconstructive surgery, with a demonstrable case volume of at least 25 to 50 implantations annually — a threshold associated with significantly lower complication rates. The 2024-2025 global survey of penile implant surgeons conducted through ESGURS and SMSNA highlights significant variation in outcomes based on surgeon experience and institutional volume, reinforcing the importance of case volume as a quality indicator. Patients should feel comfortable asking their surgeon directly about their annual implant volume, revision rates, and infection rates, and should verify membership in professional societies such as the Sexual Medicine Society of North America (SMSNA) or the European Society for Sexual Medicine (ESSM).
Selecting an appropriately trained and experienced penile implant surgeon is arguably the single most important decision a patient makes in this journey. I recommend seeking a board-certified urologist with subspecialty training in andrology or uro-oncology and reconstructive surgery, with a demonstrable case volume of at least 25 to 50 implantations annually — a threshold associated with significantly lower complication rates. The 2024-2025 global survey of penile implant surgeons conducted through ESGURS and SMSNA highlights significant variation in outcomes based on surgeon experience and institutional volume, reinforcing the importance of case volume as a quality indicator. Patients should feel comfortable asking their surgeon directly about their annual implant volume, revision rates, and infection rates, and should verify membership in professional societies such as the Sexual Medicine Society of North America (SMSNA) or the European Society for Sexual Medicine (ESSM).
→ Insurance eligibility and reimbursement
Insurance coverage for penile prosthesis implantation varies widely based on the patient's insurer, policy type, and the documented medical indication for surgery. In India, many private health insurance providers cover penile prosthesis implantation when erectile dysfunction has a clearly established organic aetiology — such as post-prostatectomy, diabetes-related neuropathy, or Peyronie's disease — and when conservative treatments have been adequately trialled and documented. A 2025 Medicare cost modelling analysis published in the International Journal of Impotence Research found significant out-of-pocket variability for ED treatments, highlighting the importance of insurance navigation. I advise patients to obtain a formal pre-authorisation letter from their insurer prior to surgery and to have my office provide comprehensive clinical documentation, including treatment failure records and validated erectile function questionnaire scores, to support the insurance claim.
Insurance coverage for penile prosthesis implantation varies widely based on the patient's insurer, policy type, and the documented medical indication for surgery. In India, many private health insurance providers cover penile prosthesis implantation when erectile dysfunction has a clearly established organic aetiology — such as post-prostatectomy, diabetes-related neuropathy, or Peyronie's disease — and when conservative treatments have been adequately trialled and documented. A 2025 Medicare cost modelling analysis published in the International Journal of Impotence Research found significant out-of-pocket variability for ED treatments, highlighting the importance of insurance navigation. I advise patients to obtain a formal pre-authorisation letter from their insurer prior to surgery and to have my office provide comprehensive clinical documentation, including treatment failure records and validated erectile function questionnaire scores, to support the insurance claim.
→ Device failure management
Mechanical failure of a penile prosthesis — typically manifesting as the inability to achieve or maintain inflation, or a spontaneous deflation — is managed by revision surgery to replace the malfunctioning component or the entire device. The 2025 systematic review on removal rates and mechanical failure by Lo Re et al. in the International Journal of Impotence Research confirms that modern devices have substantially lower failure rates than earlier-generation prostheses, though long-term mechanical issues remain the primary reason for revision procedures. In my practice, revision surgery in the absence of infection is technically straightforward, particularly if performed within the first few years, as the corporal tissue remains pliable and the device space is well-defined. Patients should be reassured that mechanical failure does not constitute a medical emergency and does not damage the surrounding anatomy — it simply requires a scheduled operative revision.
Mechanical failure of a penile prosthesis — typically manifesting as the inability to achieve or maintain inflation, or a spontaneous deflation — is managed by revision surgery to replace the malfunctioning component or the entire device. The 2025 systematic review on removal rates and mechanical failure by Lo Re et al. in the International Journal of Impotence Research confirms that modern devices have substantially lower failure rates than earlier-generation prostheses, though long-term mechanical issues remain the primary reason for revision procedures. In my practice, revision surgery in the absence of infection is technically straightforward, particularly if performed within the first few years, as the corporal tissue remains pliable and the device space is well-defined. Patients should be reassured that mechanical failure does not constitute a medical emergency and does not damage the surrounding anatomy — it simply requires a scheduled operative revision.
→ Reversibility and removal options
Yes — a penile implant can be removed, although I counsel patients clearly that removal has significant consequences and is not a casual reversible decision. Following explantation, the corpora cavernosa undergo fibrotic contraction over several months, making future re-implantation considerably more technically challenging and associated with higher risk of complications including corporal perforation. In cases of device infection, explantation is often the necessary first step, followed either by immediate salvage replacement — a technique pioneered by Mulcahy and refined significantly in subsequent decades — or delayed reimplantation after infection resolution. The INSIST-ED national registry data published in the International Journal of Impotence Research (2024) confirm that outcomes after salvage reimplantation are generally excellent in experienced centres; patients who truly wish to discontinue implant therapy can do so, but the decision warrants careful counselling.
Yes — a penile implant can be removed, although I counsel patients clearly that removal has significant consequences and is not a casual reversible decision. Following explantation, the corpora cavernosa undergo fibrotic contraction over several months, making future re-implantation considerably more technically challenging and associated with higher risk of complications including corporal perforation. In cases of device infection, explantation is often the necessary first step, followed either by immediate salvage replacement — a technique pioneered by Mulcahy and refined significantly in subsequent decades — or delayed reimplantation after infection resolution. The INSIST-ED national registry data published in the International Journal of Impotence Research (2024) confirm that outcomes after salvage reimplantation are generally excellent in experienced centres; patients who truly wish to discontinue implant therapy can do so, but the decision warrants careful counselling.
→ Surgical technique and procedure steps
The surgery is performed under spinal or general anaesthesia through either an infrapubic incision (a small transverse incision just above the base of the penis) or a penoscrotal incision (at the junction of the penile shaft and scrotum). The corpora cavernosa are identified, incised, and carefully dilated using sequential Hegar dilators to create space for the implant cylinders. In the three-piece inflatable system, the pump is placed in the scrotum and the reservoir is positioned retropubically in the prevesical space via a separate incision or the same wound. The 2024 review of minimally invasive infrapubic approaches in Andrologia confirms that the infrapubic incision offers ergonomic reservoir placement and is associated with lower rates of scrotal pump malposition, while the penoscrotal approach offers better visibility in obese patients. The entire procedure in experienced hands takes under 90 minutes.
The surgery is performed under spinal or general anaesthesia through either an infrapubic incision (a small transverse incision just above the base of the penis) or a penoscrotal incision (at the junction of the penile shaft and scrotum). The corpora cavernosa are identified, incised, and carefully dilated using sequential Hegar dilators to create space for the implant cylinders. In the three-piece inflatable system, the pump is placed in the scrotum and the reservoir is positioned retropubically in the prevesical space via a separate incision or the same wound. The 2024 review of minimally invasive infrapubic approaches in Andrologia confirms that the infrapubic incision offers ergonomic reservoir placement and is associated with lower rates of scrotal pump malposition, while the penoscrotal approach offers better visibility in obese patients. The entire procedure in experienced hands takes under 90 minutes.
→ Safety and infection prevention
Infection remains the most feared complication of penile prosthesis surgery, as it typically necessitates device explantation and results in significant patient distress. The large 2025 real-world analysis of 18,475 patients published in the Journal of Sexual Medicine reported a 3-year post-IPP infection rate of 3.1%, with 2.5% of infections occurring within the first 6 months. Risk factors include diabetes mellitus with elevated HbA1c, spinal cord injury, revision surgery, and immunosuppression — with revision cases carrying infection rates of 7 to 18% compared to 1 to 3% for primary implantations, as confirmed by the 2024 narrative review in Translational Andrology and Urology. In my practice, I employ antibiotic-impregnated implants (AMS InhibiZone or Coloplast Titan with hydrophilic coating), the 'no-touch' surgical technique, rigorous antibiotic prophylaxis, and meticulous pre-operative risk optimisation to minimise infection risk maximally.
Infection remains the most feared complication of penile prosthesis surgery, as it typically necessitates device explantation and results in significant patient distress. The large 2025 real-world analysis of 18,475 patients published in the Journal of Sexual Medicine reported a 3-year post-IPP infection rate of 3.1%, with 2.5% of infections occurring within the first 6 months. Risk factors include diabetes mellitus with elevated HbA1c, spinal cord injury, revision surgery, and immunosuppression — with revision cases carrying infection rates of 7 to 18% compared to 1 to 3% for primary implantations, as confirmed by the 2024 narrative review in Translational Andrology and Urology. In my practice, I employ antibiotic-impregnated implants (AMS InhibiZone or Coloplast Titan with hydrophilic coating), the 'no-touch' surgical technique, rigorous antibiotic prophylaxis, and meticulous pre-operative risk optimisation to minimise infection risk maximally.
→ Activation timeline post-implantation
No — the implant must not be activated or cycled in the immediate post-operative period. I instruct patients to keep the device in the fully deflated position for the first 4 to 6 weeks to allow healing of the corporal incisions, subcutaneous tissues, and scrotal pump pocket. At the 4-to-6 week post-operative visit, I personally instruct every patient in the inflation and deflation technique using a step-by-step demonstration, and I prescribe a daily cycling protocol to prevent adhesion of the cylinders to surrounding tissue and maintain corporal elasticity. Full sexual activity — including intercourse — is typically cleared at 6 to 8 weeks post-operatively, provided wound healing is complete and device cycling is performing correctly; premature activation risks incision disruption and device malposition.
No — the implant must not be activated or cycled in the immediate post-operative period. I instruct patients to keep the device in the fully deflated position for the first 4 to 6 weeks to allow healing of the corporal incisions, subcutaneous tissues, and scrotal pump pocket. At the 4-to-6 week post-operative visit, I personally instruct every patient in the inflation and deflation technique using a step-by-step demonstration, and I prescribe a daily cycling protocol to prevent adhesion of the cylinders to surrounding tissue and maintain corporal elasticity. Full sexual activity — including intercourse — is typically cleared at 6 to 8 weeks post-operatively, provided wound healing is complete and device cycling is performing correctly; premature activation risks incision disruption and device malposition.
→ Relationship counselling and support
Partner involvement is a critically undervalued component of the penile prosthesis journey, and the research evidence unequivocally supports its importance. The 2025 Corona et al. meta-analysis demonstrated that partner satisfaction rates were consistently high — exceeding 80% in most cohorts — when partners were engaged in pre-operative counselling and had realistic expectations set for them. Relationship anxiety, performance pressure, and fear of device failure are all significantly reduced when partners are educated about how the device works, what changes in intercourse to anticipate, and how to support their partner during recovery. In my practice, I encourage couples to attend at least the pre-operative and post-operative device training appointments together, and I maintain a low threshold for referring patients and partners to a certified psychosexual counsellor when indicated.
Partner involvement is a critically undervalued component of the penile prosthesis journey, and the research evidence unequivocally supports its importance. The 2025 Corona et al. meta-analysis demonstrated that partner satisfaction rates were consistently high — exceeding 80% in most cohorts — when partners were engaged in pre-operative counselling and had realistic expectations set for them. Relationship anxiety, performance pressure, and fear of device failure are all significantly reduced when partners are educated about how the device works, what changes in intercourse to anticipate, and how to support their partner during recovery. In my practice, I encourage couples to attend at least the pre-operative and post-operative device training appointments together, and I maintain a low threshold for referring patients and partners to a certified psychosexual counsellor when indicated.
→ Activity restrictions and healing guidelines
During the recovery period, I provide every patient with a structured list of restrictions to maximise healing and minimise complication risk. Sexual intercourse is prohibited for 6 to 8 weeks; heavy physical exertion, cycling, swimming, and gym activity should be avoided for at least 4 to 6 weeks. Alcohol in excess should be minimised due to its vasodilatory and delayed healing effects; smoking, which significantly impairs wound healing through vasoconstriction and oxygen delivery compromise, should be stopped entirely — ideally pre-operatively. Constipation should be avoided and managed with stool softeners to prevent straining and potential reservoir displacement; I prescribe prophylactic laxatives routinely. Tight undergarments that compress the scrotal pump should be avoided, and patients are advised to wear snug but not restrictive supportive underwear to reduce dependent oedema.
During the recovery period, I provide every patient with a structured list of restrictions to maximise healing and minimise complication risk. Sexual intercourse is prohibited for 6 to 8 weeks; heavy physical exertion, cycling, swimming, and gym activity should be avoided for at least 4 to 6 weeks. Alcohol in excess should be minimised due to its vasodilatory and delayed healing effects; smoking, which significantly impairs wound healing through vasoconstriction and oxygen delivery compromise, should be stopped entirely — ideally pre-operatively. Constipation should be avoided and managed with stool softeners to prevent straining and potential reservoir displacement; I prescribe prophylactic laxatives routinely. Tight undergarments that compress the scrotal pump should be avoided, and patients are advised to wear snug but not restrictive supportive underwear to reduce dependent oedema.
→ Age considerations for younger patients
Yes — penile prosthesis implantation is an appropriate and effective treatment for younger men with refractory organic erectile dysfunction, regardless of age. A 2025 study published in the International Journal of Urology by Sevinc et al. specifically evaluated 64 patients under 40 years of age who underwent penile prosthesis implantation between 2006 and 2024, finding a mean age of 31.7 years, with vascular causes identified in 64% of cases and only a 4.7% revision rate over a median 7-year follow-up. In younger patients, I prefer three-piece inflatable devices specifically for their superior cosmetic concealment and the more natural quality of erection they provide, which is particularly important to younger men and their partners. Pre-operative psychological assessment and honest counselling about device lifespan, the possibility of future revision surgery, and the permanent nature of the corporal dilation are mandatory components of my approach in this demographic.
Yes — penile prosthesis implantation is an appropriate and effective treatment for younger men with refractory organic erectile dysfunction, regardless of age. A 2025 study published in the International Journal of Urology by Sevinc et al. specifically evaluated 64 patients under 40 years of age who underwent penile prosthesis implantation between 2006 and 2024, finding a mean age of 31.7 years, with vascular causes identified in 64% of cases and only a 4.7% revision rate over a median 7-year follow-up. In younger patients, I prefer three-piece inflatable devices specifically for their superior cosmetic concealment and the more natural quality of erection they provide, which is particularly important to younger men and their partners. Pre-operative psychological assessment and honest counselling about device lifespan, the possibility of future revision surgery, and the permanent nature of the corporal dilation are mandatory components of my approach in this demographic.
→ Device lifespan and durability
The longevity of modern inflatable penile prostheses is impressive and continues to improve with each device generation. The landmark 2025 study by Moncada et al. published in the Asian Journal of Andrology tracked device survival of three-piece inflatable prostheses over 27 years using Kaplan-Meier analysis at a single high-volume centre, confirming excellent long-term mechanical reliability. In clinical practice, I counsel patients to expect device lifespans of 10 to 15 years under normal usage, with many devices performing well beyond this timeframe. The primary causes of long-term device replacement are mechanical failure of cylinders or tubing connections — not infection — and with newer enhanced-weave cylinders and reinforced tubing, failure rates have decreased substantially compared to devices from the 1990s and early 2000s.
The longevity of modern inflatable penile prostheses is impressive and continues to improve with each device generation. The landmark 2025 study by Moncada et al. published in the Asian Journal of Andrology tracked device survival of three-piece inflatable prostheses over 27 years using Kaplan-Meier analysis at a single high-volume centre, confirming excellent long-term mechanical reliability. In clinical practice, I counsel patients to expect device lifespans of 10 to 15 years under normal usage, with many devices performing well beyond this timeframe. The primary causes of long-term device replacement are mechanical failure of cylinders or tubing connections — not infection — and with newer enhanced-weave cylinders and reinforced tubing, failure rates have decreased substantially compared to devices from the 1990s and early 2000s.
→ Post-operative pain management
Post-operative pain after penile prosthesis implantation is real but highly manageable with contemporary multimodal analgesia protocols. Most patients describe the first 48 to 72 hours as the most uncomfortable period, characterised by a dull aching or throbbing sensation in the perineum and scrotum, compounded by scrotal swelling. I prescribe a combination of scheduled paracetamol, anti-inflammatory agents, and short-course low-dose opioid analgesia for the first 5 to 7 days. The 2024 Asian Journal of Andrology comprehensive review on pain management in penile implant surgery emphasises the importance of pre-emptive analgesia and intra-operative local anaesthetic infiltration to reduce immediate post-operative pain burden. By 2 weeks, the majority of my patients have transitioned entirely to over-the-counter analgesia if required, and most report being pain-free by 3 to 4 weeks post-operatively.
Post-operative pain after penile prosthesis implantation is real but highly manageable with contemporary multimodal analgesia protocols. Most patients describe the first 48 to 72 hours as the most uncomfortable period, characterised by a dull aching or throbbing sensation in the perineum and scrotum, compounded by scrotal swelling. I prescribe a combination of scheduled paracetamol, anti-inflammatory agents, and short-course low-dose opioid analgesia for the first 5 to 7 days. The 2024 Asian Journal of Andrology comprehensive review on pain management in penile implant surgery emphasises the importance of pre-emptive analgesia and intra-operative local anaesthetic infiltration to reduce immediate post-operative pain burden. By 2 weeks, the majority of my patients have transitioned entirely to over-the-counter analgesia if required, and most report being pain-free by 3 to 4 weeks post-operatively.
→ Urinary function post-surgery
Penile prosthesis implantation does not directly affect the lower urinary tract; the procedure is contained entirely within the corpora cavernosa and the retropubic prevesical space for the reservoir. In the immediate post-operative period, a urinary catheter may be placed intra-operatively and removed before discharge or on the first post-operative morning; some patients experience transient urinary urgency or mild dysuria related to catheter use, which resolves rapidly. In men who have underlying benign prostatic enlargement or voiding dysfunction co-existing with erectile dysfunction — a common clinical scenario — these urinary symptoms are managed separately and are unrelated to the implant. I proactively assess voiding function pre-operatively in all patients, and in selected cases I may address both conditions simultaneously or sequentially.
Penile prosthesis implantation does not directly affect the lower urinary tract; the procedure is contained entirely within the corpora cavernosa and the retropubic prevesical space for the reservoir. In the immediate post-operative period, a urinary catheter may be placed intra-operatively and removed before discharge or on the first post-operative morning; some patients experience transient urinary urgency or mild dysuria related to catheter use, which resolves rapidly. In men who have underlying benign prostatic enlargement or voiding dysfunction co-existing with erectile dysfunction — a common clinical scenario — these urinary symptoms are managed separately and are unrelated to the implant. I proactively assess voiding function pre-operatively in all patients, and in selected cases I may address both conditions simultaneously or sequentially.
→ Travel restrictions during recovery
I advise patients to avoid long-haul air travel and prolonged road journeys for the first 4 weeks post-operatively, for several important reasons. Extended immobility during travel increases the risk of deep vein thrombosis; the vibration and positioning of prolonged sitting can cause discomfort to the healing perineal and scrotal wound; and being far from your surgical team during the critical early complication window is medically inadvisable. Short domestic travel — within 1 to 2 hours of your surgical centre — is generally acceptable after 2 weeks in patients who are recovering normally. Patients should carry a physician's letter documenting their implanted device for airport security screening, as the metallic components of the pump mechanism may occasionally trigger metal detectors; I provide this documentation routinely at discharge.
I advise patients to avoid long-haul air travel and prolonged road journeys for the first 4 weeks post-operatively, for several important reasons. Extended immobility during travel increases the risk of deep vein thrombosis; the vibration and positioning of prolonged sitting can cause discomfort to the healing perineal and scrotal wound; and being far from your surgical team during the critical early complication window is medically inadvisable. Short domestic travel — within 1 to 2 hours of your surgical centre — is generally acceptable after 2 weeks in patients who are recovering normally. Patients should carry a physician's letter documenting their implanted device for airport security screening, as the metallic components of the pump mechanism may occasionally trigger metal detectors; I provide this documentation routinely at discharge.
→ Operation and activation instructions
Using an inflatable penile prosthesis is straightforward and becomes second nature to patients within a few weeks of device activation. To inflate, the patient locates the pump in the scrotum — typically positioned on the right side — and squeezes it repeatedly, typically 8 to 12 times, transferring saline from the reservoir into the cylinders to create a rigid erection. To deflate, the patient presses and holds the release valve located at the base of the pump for 3 to 5 seconds, allowing fluid return and achieving flaccidity. At my post-operative training visit — typically at 4 to 6 weeks — I personally supervise device cycling with the patient present, using a step-by-step demonstration, and provide printed instruction material. Modern devices such as the Coloplast Titan and AMS 700 series are engineered for ease of use, including for patients with limited dexterity.
Using an inflatable penile prosthesis is straightforward and becomes second nature to patients within a few weeks of device activation. To inflate, the patient locates the pump in the scrotum — typically positioned on the right side — and squeezes it repeatedly, typically 8 to 12 times, transferring saline from the reservoir into the cylinders to create a rigid erection. To deflate, the patient presses and holds the release valve located at the base of the pump for 3 to 5 seconds, allowing fluid return and achieving flaccidity. At my post-operative training visit — typically at 4 to 6 weeks — I personally supervise device cycling with the patient present, using a step-by-step demonstration, and provide printed instruction material. Modern devices such as the Coloplast Titan and AMS 700 series are engineered for ease of use, including for patients with limited dexterity.
→ Impact on sexual confidence and intimacy
The evidence strongly supports a positive impact of penile prosthesis implantation on relationship quality and sexual confidence. The 2025 meta-analysis by Corona et al. demonstrated that the benefit of penile prosthesis extends well beyond individual patient satisfaction — partner satisfaction exceeded 80%, and multiple studies have shown significant improvements in relationship intimacy, couple communication, and overall quality of life. A study referenced in contemporary patient satisfaction literature found that 79% of patients and 82% of their partners reported satisfying improvements in sexual life, with a further 13% reporting moderate improvement. In my practice, I counsel patients that the implant provides the physiological foundation for intimacy — the psychological rebuilding, confidence restoration, and relationship reconnection that follows is a journey that often benefits from concurrent psychosexual support.
The evidence strongly supports a positive impact of penile prosthesis implantation on relationship quality and sexual confidence. The 2025 meta-analysis by Corona et al. demonstrated that the benefit of penile prosthesis extends well beyond individual patient satisfaction — partner satisfaction exceeded 80%, and multiple studies have shown significant improvements in relationship intimacy, couple communication, and overall quality of life. A study referenced in contemporary patient satisfaction literature found that 79% of patients and 82% of their partners reported satisfying improvements in sexual life, with a further 13% reporting moderate improvement. In my practice, I counsel patients that the implant provides the physiological foundation for intimacy — the psychological rebuilding, confidence restoration, and relationship reconnection that follows is a journey that often benefits from concurrent psychosexual support.
→ Comparing implant manufacturers and models
The two dominant manufacturers of inflatable penile prostheses globally are Boston Scientific (AMS 700 series, formerly American Medical Systems) and Coloplast (Titan series). The AMS 700CX and AMS 700LGX differ primarily in cylinder design: the CX is a controlled-expansion cylinder offering excellent rigidity, while the LGX provides both girth and length expansion — useful in patients seeking maximal length restoration. The Coloplast Titan features a unique hydrophilic surface coating that absorbs antibiotic solution intra-operatively, significantly reducing infection risk, and it is available in a Zero Degree Angle variant designed for improved concealment. A comparison study referenced in the Asian Journal of Andrology demonstrated comparable patient and partner satisfaction between the AMS 700CX and Coloplast Titan, with device selection appropriately individualised to patient anatomy, risk profile, and surgeon preference.
The two dominant manufacturers of inflatable penile prostheses globally are Boston Scientific (AMS 700 series, formerly American Medical Systems) and Coloplast (Titan series). The AMS 700CX and AMS 700LGX differ primarily in cylinder design: the CX is a controlled-expansion cylinder offering excellent rigidity, while the LGX provides both girth and length expansion — useful in patients seeking maximal length restoration. The Coloplast Titan features a unique hydrophilic surface coating that absorbs antibiotic solution intra-operatively, significantly reducing infection risk, and it is available in a Zero Degree Angle variant designed for improved concealment. A comparison study referenced in the Asian Journal of Andrology demonstrated comparable patient and partner satisfaction between the AMS 700CX and Coloplast Titan, with device selection appropriately individualised to patient anatomy, risk profile, and surgeon preference.
→ Clothing and lifestyle adjustments
In the early post-operative recovery period — the first 6 weeks — I advise patients to wear supportive but non-compressive underwear, such as fitted boxer briefs, which elevate the scrotum comfortably and reduce dependent oedema without compressing the scrotal pump. Once fully healed, patients with penile implants can generally wear any style of underwear comfortably, including fitted styles, with no adverse effect on device function. The scrotal pump is soft and pliable and conforms readily to the scrotal anatomy; patients often describe it as feeling like a third testicle in texture after full capsular formation. I advise patients against very tight compression shorts or bicycle shorts during vigorous exercise long-term, as sustained perineal pressure over the pump theoretically risks component malposition, though this is rarely reported clinically.
In the early post-operative recovery period — the first 6 weeks — I advise patients to wear supportive but non-compressive underwear, such as fitted boxer briefs, which elevate the scrotum comfortably and reduce dependent oedema without compressing the scrotal pump. Once fully healed, patients with penile implants can generally wear any style of underwear comfortably, including fitted styles, with no adverse effect on device function. The scrotal pump is soft and pliable and conforms readily to the scrotal anatomy; patients often describe it as feeling like a third testicle in texture after full capsular formation. I advise patients against very tight compression shorts or bicycle shorts during vigorous exercise long-term, as sustained perineal pressure over the pump theoretically risks component malposition, though this is rarely reported clinically.
→ Medical prerequisites and qualifications
Candidacy for penile prosthesis implantation is established through a systematic clinical evaluation. The core prerequisite is documented, organic erectile dysfunction that has been refractory to adequate trials of first-line (PDE5 inhibitors) and second-line (intracavernosal injection therapy or vacuum erection device) treatments. Medical conditions commonly associated with implant candidacy include: post-radical prostatectomy ED, Peyronie's disease with concurrent ED, diabetes-associated vasculogenic or neurogenic ED, and post-priapism cavernosal fibrosis. The 2024 StatPearls update on penile prosthesis candidacy highlights that pre-operative optimisation of modifiable risk factors — particularly glycaemic control (targeting HbA1c below 8.5%), smoking cessation, and cardiovascular fitness — is mandatory before proceeding. Psychological readiness, realistic expectations, and ideally partner consent are additional pillars I assess during the candidacy consultation.
Candidacy for penile prosthesis implantation is established through a systematic clinical evaluation. The core prerequisite is documented, organic erectile dysfunction that has been refractory to adequate trials of first-line (PDE5 inhibitors) and second-line (intracavernosal injection therapy or vacuum erection device) treatments. Medical conditions commonly associated with implant candidacy include: post-radical prostatectomy ED, Peyronie's disease with concurrent ED, diabetes-associated vasculogenic or neurogenic ED, and post-priapism cavernosal fibrosis. The 2024 StatPearls update on penile prosthesis candidacy highlights that pre-operative optimisation of modifiable risk factors — particularly glycaemic control (targeting HbA1c below 8.5%), smoking cessation, and cardiovascular fitness — is mandatory before proceeding. Psychological readiness, realistic expectations, and ideally partner consent are additional pillars I assess during the candidacy consultation.
→ Pre-operative instructions and requirements
Pre-operative preparation for penile prosthesis implantation begins several weeks before the surgical date. I require all diabetic patients to achieve optimal glycaemic control with HbA1c ideally below 8.5%, as elevated perioperative glucose significantly increases infection risk — a threshold validated by the 2025 study on high-risk patients published in Translational Andrology and Urology. Patients are instructed to stop aspirin and anticoagulants (with medical team guidance), stop smoking at least 4 weeks pre-operatively, and undergo a thorough pre-anaesthetic assessment. On the day of surgery, patients receive prophylactic intravenous antibiotics, undergo scrotal and penile skin preparation with chlorhexidine, and have urinary catheterisation performed in the operating theatre. I provide each patient with a detailed printed pre-operative instruction sheet at their final pre-surgical visit.
Pre-operative preparation for penile prosthesis implantation begins several weeks before the surgical date. I require all diabetic patients to achieve optimal glycaemic control with HbA1c ideally below 8.5%, as elevated perioperative glucose significantly increases infection risk — a threshold validated by the 2025 study on high-risk patients published in Translational Andrology and Urology. Patients are instructed to stop aspirin and anticoagulants (with medical team guidance), stop smoking at least 4 weeks pre-operatively, and undergo a thorough pre-anaesthetic assessment. On the day of surgery, patients receive prophylactic intravenous antibiotics, undergo scrotal and penile skin preparation with chlorhexidine, and have urinary catheterisation performed in the operating theatre. I provide each patient with a detailed printed pre-operative instruction sheet at their final pre-surgical visit.
→ Cosmetic outcomes and scar appearance
The incisions used in penile prosthesis implantation are small and strategically placed to minimise visible scarring. The infrapubic incision is a 3-to-4 centimetre transverse incision hidden in the pubic hairline, which typically heals to a barely visible fine scar within 3 to 6 months. The penoscrotal incision is located at the penoscrotal junction — a natural skin fold — and heals even more inconspicuously due to the natural texture and rugosity of scrotal skin. The 2024 review of mid-term outcomes of the minimally invasive infrapubic approach in Andrologia confirmed excellent cosmetic outcomes with no patients reporting scar-related dissatisfaction. I use absorbable sutures throughout and routinely employ scar minimisation techniques including layered closure and, when indicated, topical scar management preparations after complete wound healing.
The incisions used in penile prosthesis implantation are small and strategically placed to minimise visible scarring. The infrapubic incision is a 3-to-4 centimetre transverse incision hidden in the pubic hairline, which typically heals to a barely visible fine scar within 3 to 6 months. The penoscrotal incision is located at the penoscrotal junction — a natural skin fold — and heals even more inconspicuously due to the natural texture and rugosity of scrotal skin. The 2024 review of mid-term outcomes of the minimally invasive infrapubic approach in Andrologia confirmed excellent cosmetic outcomes with no patients reporting scar-related dissatisfaction. I use absorbable sutures throughout and routinely employ scar minimisation techniques including layered closure and, when indicated, topical scar management preparations after complete wound healing.
→ Medical condition compatibility
Diabetes mellitus is one of the most common underlying aetiologies driving patients to penile prosthesis implantation, and it is absolutely not a contraindication to surgery — though it does require meticulous pre-operative optimisation. The key risk in diabetic patients is elevated infection susceptibility; the 2025 meta-analysis and 2024 umbrella review both identify elevated HbA1c as the strongest modifiable predictor of post-operative device infection, with weighted mean HbA1c of 8.37% in infected versus 7.17% in non-infected cases. In my practice, I require all diabetic patients to achieve HbA1c below 8.5% before scheduling surgery, coordinate with their endocrinologist for perioperative glycaemic management, and use antibiotic-impregnated prostheses as standard. With these precautions, outcomes in well-controlled diabetic patients are excellent, and a systematic review by Christodoulidou confirmed that infection rates in diabetic patients have declined substantially with modern device technology and surgical expertise.
Diabetes mellitus is one of the most common underlying aetiologies driving patients to penile prosthesis implantation, and it is absolutely not a contraindication to surgery — though it does require meticulous pre-operative optimisation. The key risk in diabetic patients is elevated infection susceptibility; the 2025 meta-analysis and 2024 umbrella review both identify elevated HbA1c as the strongest modifiable predictor of post-operative device infection, with weighted mean HbA1c of 8.37% in infected versus 7.17% in non-infected cases. In my practice, I require all diabetic patients to achieve HbA1c below 8.5% before scheduling surgery, coordinate with their endocrinologist for perioperative glycaemic management, and use antibiotic-impregnated prostheses as standard. With these precautions, outcomes in well-controlled diabetic patients are excellent, and a systematic review by Christodoulidou confirmed that infection rates in diabetic patients have declined substantially with modern device technology and surgical expertise.
Before recommending penile prosthesis implantation, I ensure all patients have adequately trialled PDE5 inhibitors (sildenafil, tadalafil, vardenafil), vacuum erection devices, and intracavernosal injection therapy with alprostadil or combination formulations. Low-intensity shockwave therapy (LiSWT) is an emerging option with growing evidence, particularly for vasculogenic ED, and may restore natural erectile function in select patients. However, for men with severe organic ED, especially post-prostatectomy or diabetic neuropathic aetiology, medical therapies typically offer limited benefit, and the prosthesis provides the most reliable, durable, and satisfying long-term solution.
Erectile dysfunction remains a profoundly under-reported condition, with most men delaying consultation by 2 or more years after symptom onset due to embarrassment or cultural stigma. I encourage all men experiencing ED to approach the conversation directly, using the terminology 'erectile dysfunction' or 'difficulty achieving or maintaining an erection,' and to document symptom duration, severity, and any associated factors such as reduced libido, urinary symptoms, or cardiovascular risk factors. Remember that for urologists such as myself, ED is a daily clinical discussion — there is no aspect of this condition that is unusual or embarrassing in the clinical setting, and early consultation allows the widest range of treatment options to be explored.
While a penile prosthesis is a mechanical solution, lifestyle optimisation profoundly influences the surgical outcome and the longevity of the device. Cessation of smoking is paramount — smoking impairs wound healing, increases infection risk, and accelerates vascular deterioration of corporal tissue. Glycaemic control in diabetic patients, weight management, cardiovascular fitness, and adequate sleep all contribute to peri-operative safety and recovery quality. I also strongly advocate for pelvic floor physiotherapy post-implantation, which strengthens the ischiocavernosus and bulbocavernosus muscles, improving the rigidity experienced with device use and enhancing ejaculatory function.
I structure post-operative follow-up appointments at specific intervals: a wound check at 1 week, device activation and training at 4 to 6 weeks, sexual activity clearance at 6 to 8 weeks, and a comprehensive outcomes review at 3 months. At the 4-to-6 week visit — the most important of all post-operative appointments — I personally instruct the patient in device inflation and deflation technique, assess for any early complications, and prescribe a daily cycling protocol. Long-term follow-up is recommended annually, as device mechanical issues are more likely to be identified and addressed early in the context of an ongoing surgical relationship. Patients are always given direct contact access to my team for any concerns between scheduled appointments.
Several pervasive myths surround penile prosthesis implantation that I routinely dispel. Myth: 'The implant creates an erection automatically' — Fact: the patient must actively inflate the device. Myth: 'You lose all feeling' — Fact: penile sensation and orgasmic function are completely preserved. Myth: 'It's obvious to a partner' — Fact: when properly positioned and deflated, the device is essentially undetectable. Myth: 'It's only for older men' — Fact: the 2025 Sevinc et al. study demonstrates excellent outcomes in men under 40. Myth: 'It cures the underlying cause of ED' — Fact: it restores sexual function mechanically without treating the underlying vascular or neurological aetiology.
Beyond its physical function, penile prosthesis implantation carries significant psychological and psychosocial benefits. Erectile dysfunction is independently associated with depression, anxiety, and diminished self-esteem, and restoration of erectile function through prosthetic implantation demonstrably improves these domains. Research consistently demonstrates improvements in self-confidence, reduced performance anxiety, restoration of masculine identity, and enhanced relationship satisfaction following implantation. I routinely screen patients for depression and anxiety pre-operatively using validated tools, and I incorporate psychosexual counselling referrals into the care pathway for patients with significant psychological comorbidity, as untreated psychological factors are one of the few modifiable predictors of post-operative dissatisfaction.
Partner support during the recovery period is not merely helpful — it is clinically significant. Partners who are educated about the recovery timeline, device mechanics, and realistic post-operative expectations are far more likely to be patient, supportive, and ultimately satisfied with outcomes. I provide partners with dedicated educational materials at the pre-operative consultation and actively encourage attendance at the device training appointment. Practical support during recovery includes assistance with wound care, management of post-operative discomfort, and emotional reassurance during the 6-to-8 week period before intercourse is resumed. Partners should be advised that the first few sexual encounters post-activation may feel unfamiliar and may require patience, communication, and gentle experimentation as both partners adapt.
When evaluating ED treatment costs over a 5-to-10 year horizon, penile prosthesis implantation is frequently the most cost-effective option for men with severe organic ED who have failed medical therapies. PDE5 inhibitors taken daily or on-demand accumulate significant monthly costs — often USD 50 to 200 per month internationally — while intracavernosal injection therapies require ongoing pharmacy expenditure and consumable costs. A 2025 Medicare cost modelling study in the International Journal of Impotence Research highlighted the substantial out-of-pocket burden of ongoing ED medications, particularly in Medicare populations. In contrast, a penile prosthesis — amortised over its 10-to-15 year functional lifespan — often represents a lower total cost of treatment while delivering the highest patient satisfaction of all available ED therapies.
CLINICAL DISCLAIMER: The information provided in this document is intended for general educational purposes and represents Dr. Arif Akhtar's clinical perspectives informed by current peer-reviewed literature. It does not constitute personalised medical advice. All treatment decisions should be made in the context of an individual clinical consultation.
Prostate Cancer: Treatment, Recovery & Workplace Guide
Prostate cancer is one of the most common cancers affecting men, but early detection and modern treatment options have significantly improved outcomes and quality of life. Depending on the stage and severity of the disease, treatment may include active surveillance, robotic surgery, radiation therapy, hormone therapy, or a combination of approaches. Most patients can continue working or return to normal activities during recovery with appropriate planning and support. In this FAQ guide, Dr. Arif Akhtar answers common questions about prostate cancer symptoms, diagnosis, treatment, recovery, workplace considerations, and long-term health after treatment.
Most office workers return within two to six weeks.
Yes. Many patients continue working throughout treatment.
Usually not, although fatigue may require temporary adjustments.
A specialist consultation helps establish realistic recovery expectations based on your specific treatment plan.
No. The treatment itself is painless.
Most patients can.
Many patients continue working without requiring leave.
Patients considering radiation therapy should discuss expected side effects and work-related planning before treatment begins.
Most patients continue working successfully.
Fatigue.
Yes. Exercise remains one of the best proven interventions.
Patients receiving ADT should undergo regular monitoring and discuss side effect management early.
In most cases, no. Most patients successfully continue or resume employment.
Yes. Many patients continue full-time employment during radiation treatment.
Most office workers return within two to six weeks.
Any man with elevated PSA levels, urinary symptoms, family history of prostate cancer, or concerns regarding screening should seek expert evaluation.
Changes should be based on actual work requirements, not assumptions about your diagnosis.
Generally no. Employers usually only need information relevant to workplace planning.
In many workplaces, yes.
If you have recently been diagnosed with prostate cancer, discussing expected treatment timelines and recovery can help with workplace planning.
Not necessarily. Many patients continue working during treatment.
Most office workers return within two to six weeks.
Yes, many patients do.
A specialist can help estimate recovery timelines based on your treatment plan.
A diagnosis alone should not determine employment decisions.
If treatment affects work schedules or performance, early communication is usually helpful.
Yes. Many patients continue working successfully with temporary workplace adjustments.
Early consultation helps establish realistic treatment and recovery expectations.
Many patients qualify for medical leave depending on workplace policies.
In most cases, temporary leave does not affect long-term career prospects.
Yes. Early planning is strongly recommended.
If treatment planning may affect employment or recovery timelines, a consultation can provide realistic expectations.
No. Disclosure is entirely your choice.
Only what you feel comfortable discussing.
Many patients find workplace support extremely valuable.
Patients diagnosed with prostate cancer should discuss treatment timelines and recovery expectations early to help with workplace planning.
Many patients successfully do so.
It often improves comfort and flexibility but should not replace proper rest.
Temporary remote work can be beneficial during recovery.
Patients considering treatment should discuss anticipated recovery timelines and workplace planning during consultation.
In some situations, yes.
Duration varies depending on treatment and recovery.
Often yes, with medical clearance.
Patients should discuss anticipated recovery periods before treatment begins.
For most patients, absolutely not.
Yes.
Early diagnosis often results in less disruption and better outcomes.
Men with elevated PSA levels or concerning symptoms should seek early evaluation.
Yes, many patients benefit from schedule adjustments.
Sometimes.
Usually not.
Discuss anticipated side effects and recovery expectations before treatment begins.
Yes, particularly during radiation and hormone therapy.
Appropriate exercise usually improves energy levels.
If fatigue becomes severe or persistent.
Persistent symptoms should always be discussed with your treatment team.
Most men with prostate cancer do not need to quit their jobs. Temporary leave, flexible schedules, or reduced hours are often sufficient while undergoing treatment. Major career decisions should ideally be made after recovery rather than during a stressful period.
Medical leave programs can help patients attend treatments and recover without unnecessary employment concerns. Early planning and communication with employers can make the process smoother. Always understand your organization’s leave policies before treatment begins.
Approach the conversation professionally and focus on how treatment may affect your schedule rather than discussing every medical detail. Early communication allows employers to provide support and plan workloads effectively.
Part-time work can be an excellent option for patients experiencing fatigue or frequent medical appointments. It allows continued professional engagement while prioritizing recovery and wellbeing.
A prostate cancer diagnosis can lead to anxiety, sleep disturbances, and reduced concentration. Regular exercise, social support, and professional counseling can significantly improve emotional wellbeing during treatment.
Most workplace policies protect employees from unfair treatment based solely on a cancer diagnosis. Understanding your rights and communicating openly with employers can help reduce anxiety and improve workplace support.
Recovery varies depending on treatment type. Many patients return to office-based work within weeks after robotic surgery, while radiation therapy often allows continued employment throughout treatment.
Fatigue, urinary symptoms, and hormonal changes are the most common treatment-related challenges. Most side effects can be managed effectively with proper medical support and workplace flexibility.
Understanding insurance benefits before treatment begins helps avoid unexpected expenses. Review coverage for surgery, radiation therapy, medications, and follow-up care.
Many men experience temporary changes in confidence after treatment. Open communication, support systems, and realistic expectations help patients regain confidence and maintain healthy relationships.
Regular physical activity is strongly encouraged during treatment. Walking, stretching, and light exercise can reduce fatigue, improve mood, and support overall recovery.
Employers may need information related to work performance or leave requests but generally do not require detailed medical records. Patients should feel comfortable maintaining reasonable privacy.
Temporary reductions in productivity may occur during treatment. Setting realistic goals, prioritizing important tasks, and allowing adequate recovery time can help maintain performance.
Review insurance benefits, anticipated treatment costs, and available workplace benefits early. Financial preparation reduces stress and allows patients to focus on recovery.
Early detection often leads to simpler treatments, faster recovery, and less disruption to work and family life. Timely screening remains one of the most effective ways to preserve quality of life.
Treatment decisions should be based primarily on medical factors rather than work commitments. Many prostate cancers allow time for careful planning, but unnecessary delays should be avoided.
Medical leave often provides greater protection and benefits than unpaid leave. Understanding available options before treatment begins helps reduce stress and improve planning.
Most patients can return to normal work schedules after radiation therapy. A gradual transition may help if fatigue or urinary symptoms persist temporarily.
Many patients continue shift work during treatment, although schedule adjustments may improve recovery. Adequate sleep and fatigue management are particularly important.
High levels of workplace stress can affect sleep, mood, and overall wellbeing. Exercise, time management, and emotional support can help patients cope more effectively.
Existing life insurance policies are usually unaffected by a diagnosis. New applications may involve additional medical review depending on treatment history and disease status.
Early detection improves cure rates and often allows less disruptive treatment options. Many patients maintain normal professional lives when cancer is diagnosed early.
Support groups provide emotional encouragement, practical advice, and reassurance. Many patients find comfort in speaking with others who have experienced similar challenges.
Some men reassess professional goals after treatment. Career changes should be based on long-term aspirations and health needs rather than temporary treatment-related stress.
With proper planning, most men successfully balance treatment and work. Open communication, realistic expectations, and attention to recovery are key to maintaining both health and career success.
Erectile dysfunction is a common concern but many effective treatments are available, including medications, vacuum devices, injections, and penile implants. Early intervention often improves outcomes.
A balanced diet rich in vegetables, fruits, lean proteins, and whole grains supports recovery and overall health. Good nutrition can also help manage treatment-related fatigue.
Robotic surgery offers smaller incisions, reduced blood loss, shorter hospital stays, and faster recovery for many patients. The experience of the surgeon remains one of the most important factors influencing outcomes.